# 外周血管设备市场 > 外周血管设备市场研究报告按设备类型（支架、导管、内支架、动脉切除设备、支架-内支架）、按应用（冠状动脉疾病、外周动脉疾病、静脉血栓栓塞、肾动脉疾病、颈动脉疾病）、按材料（金属、生物可降解、聚合物基、镍钛合金基、铂基）、按方式（侵入性、微创、非侵入性）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.52% - **2024:** $ 23.99 Billion - **2025:** $ 25.08 Billion - **2035:** $ 39.02 Billion - **Key Players:** Medtronic(US), Boston Scientific (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Cook Medical (US), Cardinal Health (US), Johnson & Johnson (US), Philips (NL) **Report ID:** MRFR/HC/28443-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/peripheral-vascular-device-market-30187 --- ## Market Summary ## **Peripheral Vascular Device Market Overview** As per MRFR analysis, the Peripheral Vascular Device Market Size was estimated at 23.99 (USD Billion) in 2024. The Peripheral Vascular Device Market Industry is expected to grow from 25.08 (USD Billion) in 2025 to 37.34 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.52% during the forecast period (2025 - 2034). ### **Key Peripheral Vascular Device Market Trends Highlighted** The Peripheral Vascular Device Market is witnessing a surge in demand due to the increasing prevalence of peripheral artery disease (PAD). The aging population and the rise in lifestyle-related diseases, such as diabetes and cardiovascular disorders, are driving the market growth. Technological advancements, such as the development of minimally invasive devices, are further contributing to the market expansion.Opportunities lie in untapped emerging markets, where the growing healthcare infrastructure and rising disposable incomes are expected to boost demand. Additionally, the focus on developing personalized and remote patient monitoring devices is creating new avenues for market growth.Recent trends include the adoption of robotic-assisted surgical procedures, which offer enhanced precision and efficiency. The integration of artificial intelligence (AI) and machine learning (ML) technologies is also gaining traction, aiding in more tailored and effective patient care. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Peripheral Vascular Device Market Drivers** ### **Increasing Prevalence of Peripheral Artery Disease** Peripheral artery disease (PAD) is a common condition that affects millions of people worldwide. It occurs when the arteries in the legs or arms become narrowed or blocked, reducing blood flow to the affected limbs. PAD can cause a variety of symptoms, including pain, numbness, and weakness in the legs or arms. In severe cases, PAD can lead to amputation. The increasing prevalence of PAD is a major driver of growth in the global peripheral vascular device market.As the population ages, the risk of developing PAD increases. Additionally, the increasing prevalence of obesity, diabetes, and smoking are also contributing to the rise in PAD cases. This is leading to a growing demand for peripheral vascular devices, such as stents, angioplasty balloons, and atherectomy devices, which are used to treat PAD. ### **Technological Advancements** Technological advancements are another major driver of growth in the global peripheral vascular device market. In recent years, there have been significant advances in the development of new and improved peripheral vascular devices. These advancements have led to the development of devices that are more effective, less invasive, and easier to use. For example, the development of drug-eluting stents has improved the long-term patency of stents and reduced the risk of restenosis.Additionally, the development of new imaging technologies has made it possible to more accurately diagnose and treat peripheral vascular disease. These technological advancements are expected to continue to drive growth in the global peripheral vascular device market in the coming years. ### **Rising Healthcare Expenditure** Rising healthcare expenditure is another factor that is driving growth in the global peripheral vascular device market. As healthcare costs continue to rise, governments and private insurers are looking for ways to reduce costs. Peripheral vascular devices can help to reduce healthcare costs by reducing the need for hospitalizations and surgeries. For example, stents can be used to treat peripheral artery disease without the need for open surgery.This can lead to significant savings in healthcare costs. Additionally, peripheral vascular devices can help to improve the quality of life for patients with peripheral vascular disease. This can lead to increased productivity and reduced absenteeism from work, which can also save money for employers. ## **Peripheral Vascular Device Market Segment Insights** ### **Peripheral Vascular Device Market Device Type Insights** The Global Peripheral Vascular Device Market is segmented into Stents, Catheters, Endografts, Atherectomy Devices, and Stent-Grafts based on Device Type. Stents are expected to dominate the market with a share of over 35% in 2023, owing to their widespread usage in treating peripheral artery disease. The increasing prevalence of cardiovascular diseases is driving the demand for stents. Additionally, technological advancements, such as the development of drug-eluting stents, are further fueling the market growth. Catheters are another major segment, accounting for a significant share of the market.They are used for diagnostic and therapeutic procedures, such as angioplasty and atherectomy.  The rising number of minimally invasive procedures is contributing to the growth of the catheter segment. Endografts are used to repair damaged blood vessels and are gaining popularity due to their ability to provide a less invasive alternative to open surgery. The increasing incidence of aortic aneurysms is expected to drive the growth of the endograft segment. Atherectomy devices are used to remove plaque from arteries and are expected to witness steady growth over the forecast period.The increasing emphasis on preventive care and the growing awareness of cardiovascular diseases are contributing to the growth of the atherectomy devices segment. Stent grafts are used to treat complex vascular conditions and offer advantages such as reduced invasiveness and shorter recovery times. The increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures are the key factors driving the market growth. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Peripheral Vascular Device Market Application Insights** The Global Peripheral Vascular Device Market is segmented into several applications, including Coronary Artery Disease, Peripheral Arterial Disease, Venous Thromboembolism, Renal Artery Disease, and Carotid Artery Disease. Coronary Artery Disease (CAD) is a condition in which the arteries that supply blood to the heart become narrowed or blocked. Peripheral Arterial Disease (PAD) is a condition in which the arteries that supply blood to the limbs become narrowed or blocked. Venous Thromboembolism (VTE) is a condition in which blood clots form in the veins.Renal Artery Disease (RAD) is a condition in which the arteries that supply blood to the kidneys become narrowed or blocked. Carotid Artery Disease (CAD) is a condition in which the arteries that supply blood to the brain become narrowed or blocked. The Global Peripheral Vascular Device Market for CAD is expected to reach USD 12.4 billion by 2024, growing at a CAGR of 4.5%. The market for PAD is expected to reach USD 6.5 billion by 2024, growing at a CAGR of 5.2%. The market for VTE is expected to reach USD 4.8 billion by 2024, growing at a CAGR of 6.1%.The market for RAD is expected to reach USD 2.7 billion by 2024, growing at a CAGR of 4.9%. The market for CAD is expected to reach USD 2.3 billion by 2024, growing at a CAGR of 4.7%. The growth of the Global Peripheral Vascular Device Market is being driven by the increasing prevalence of cardiovascular diseases, the growing demand for minimally invasive procedures, and the technological advancements in peripheral vascular devices. ### **Peripheral Vascular Device Market Material Insights** The Global Peripheral Vascular Device Market is segmented based on Material into Metallic, Biodegradable, Polymer-Based, Nitinol-Based, and Platinum-Based. Among these segments, the Metallic segment held the largest market share in 2023 and is expected to continue its dominance throughout the forecast period. The growth of this segment can be attributed to the high strength and durability of metallic materials, which make them suitable for use in demanding applications such as stents and grafts. Moreover, the increasing prevalence of peripheral artery disease and the rising number of minimally invasive procedures are expected to drive the growth of the Metallic segment in the coming years.The Biodegradable segment is expected to witness the fastest growth during the forecast period. The increasing demand for bioresorbable devices, which offer advantages such as reduced risk of infection and restenosis, is driving the growth of this segment. Additionally, ongoing advancements in biomaterial technology are expected to further contribute to the growth of the Biodegradable segment in the coming years. The Polymer-Based segment is expected to hold a significant market share during the forecast period. The versatility and low cost of polymer-based materials make them suitable for a wide range of applications in peripheral vascular devices.The increasing demand for polymer-based coatings and drug-eluting devices is expected to drive the growth of this segment in the coming years. The Nitinol-Based segment is expected to witness steady growth during the forecast period. The unique properties of Nitinol, such as its high strength, flexibility, and biocompatibility, make it a suitable material for use in peripheral vascular devices. The increasing demand for Nitinol-based stents and grafts is expected to drive the growth of this segment in the coming years. The Platinum-Based segment is expected to hold a niche market share during the forecast period.The high cost of platinum-based materials limits their widespread adoption in peripheral vascular devices. However, the excellent biocompatibility and corrosion resistance of platinum makes it a suitable material for use in high-performance devices such as pacemakers and implantable cardioverter-defibrillators (ICDs). ### **Peripheral Vascular Device Market Modality Insights** The Global Peripheral Vascular Device Market is segmented by Modality into Invasive, Minimally Invasive, and Non-Invasive. Among these, the Minimally Invasive segment held the largest market share of 42.3% in 2023 and is expected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing adoption of minimally invasive procedures, such as endovascular interventions, which offer less pain, reduced recovery time, and improved patient outcomes compared to traditional open surgeries. Furthermore, the rising prevalence of peripheral artery disease and the increasing number of minimally invasive procedures performed for the treatment of cardiovascular diseases are driving the growth of the Minimally Invasive segment.The Invasive segment is expected to witness a steady growth rate during the forecast period due to the continued use of open surgeries for complex cases and the availability of advanced surgical techniques. The Non-Invasive segment is also expected to experience significant growth owing to the increasing adoption of non-invasive imaging techniques, such as ultrasound and magnetic resonance imaging (MRI), for the diagnosis and monitoring of peripheral vascular diseases. ### **Peripheral Vascular Device Market Regional Insights** The Global Peripheral Vascular Device Market is segmented into North America, Europe, APAC, South America, and MEA. North America is expected to hold the largest market share in 2023 due to the increasing prevalence of peripheral artery disease and the presence of major market players. Europe is expected to be the second-largest market, followed by APAC. The APAC region is expected to witness significant growth due to the rising geriatric population and the increasing adoption of minimally invasive procedures. South America and MEA are expected to have a relatively smaller market share but are expected to grow at a steady pace due to the growing awareness of peripheral vascular diseases and the increasing availability of advanced healthcare infrastructure. **** Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Peripheral Vascular Device Market Key Players And Competitive Insights** Major players in the Peripheral Vascular Device Market industry are continuously engaged in developing new products and technologies to cater to the evolving needs of patients and healthcare professionals. Leading Peripheral Vascular Device Market players are investing heavily in research and development to stay competitive in the market and gain market share. The Peripheral Vascular Device Market development is also being driven by the increasing prevalence of peripheral vascular diseases and the growing demand for minimally invasive procedures. The competitive landscape of the Peripheral Vascular Device Market industry is expected to remain highly competitive in the coming years, with major players focusing on innovation, expanding their product portfolios, and strengthening their distribution networks. Medtronic plc is a leading global medical technology company that offers a wide range of Peripheral Vascular Device Market products and solutions. The company's Peripheral Vascular Device Market business unit offers a comprehensive portfolio of products for the treatment of peripheral vascular diseases, including stents, grafts, balloons, and catheters. Medtronic plc has a strong global presence and a well-established distribution network, which enables it to reach a wide range of customers. The company is also committed to innovation and has a strong track record of developing new products and technologies.Boston Scientific Corporation is another major player in the Peripheral Vascular Device Market industry. The company offers a broad range of Peripheral Vascular Device Market products and solutions for the treatment of peripheral vascular diseases, including stents, grafts, balloons, and catheters. Boston Scientific Corporation has a strong global presence and a well-established distribution network, which enables it to reach a wide range of customers. The company is also committed to innovation and has a strong track record of developing new products and technologies. ### **Key Companies in the Peripheral Vascular Device Market Include** - [Philips Healthcare](https://www.usa.philips.com/healthcare/procedure/peripheral-arterial) - LeMaitre - Braun - Siemens Healthcare - BD - Baxter International - Abbott Vascular - Cardinal Health - Boston Scientific - Stryker - Johnson Johnson (Ethicon) - Cook Medical - Medtronic - Terumo Medical Corporation - AngioDynamics ## Peripheral Vascular Device Industry Developments - **Q2 2024: MicroVention Launches LVIS EVO Intraluminal Support Device in the U.S.** MicroVention, a division of Terumo, officially launched its LVIS EVO intraluminal support device in the United States in June 2024. The new stent is designed to provide advanced intraluminal support for complex vascular conditions. ## **Peripheral Vascular Device Market Segmentation Insights** ### **Peripheral Vascular Device Market Device Type Outlook** - Stents - Catheters - Endografts - Atherectomy Devices - Stent-Grafts ### **Peripheral Vascular Device Market Application Outlook** - Coronary Artery Disease - Peripheral Arterial Disease - Venous Thromboembolism - Renal Artery Disease - Carotid Artery Disease ### **Peripheral Vascular Device Market Material Outlook** - Metallic - Biodegradable - Polymer-Based - Nitinol-Based - Platinum-Based ### **Peripheral Vascular Device Market Modality Outlook** - Invasive - Minimally Invasive - Non-Invasive ### **Peripheral Vascular Device Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### 监管支持和报销政策 监管支持和有利的报销政策在塑造外周血管设备市场中至关重要。各国政府和监管机构越来越认识到外周血管设备在改善患者结果方面的重要性。因此，创新设备的审批流程趋向于简化，这可以促进更快的市场进入。此外，覆盖这些设备的报销政策对于鼓励医疗服务提供者的采用至关重要。市场数据显示，拥有支持性报销框架的地区可能会经历更高的设备使用增长率。这种监管环境不仅促进了创新，还提高了患者的可及性，从而推动了整体市场的扩展。 ### 对微创手术需求的增加 向微创手术的转变正在显著影响外周血管设备市场。患者和医疗服务提供者越来越倾向于这些技术，因为它们带来的好处，如缩短恢复时间和降低并发症率。因此，对促进这些手术的设备的需求不断增长，包括基于导管的干预和血管内支架。市场分析表明，微创细分市场预计将迅速扩张，未来几年复合年增长率（CAGR）预计超过8%。这一趋势可能会推动制造商之间的创新和竞争，因为他们努力开发满足微创技术特定要求的设备。 ### 设备设计中的技术创新 技术进步在塑造外周血管设备市场中发挥着至关重要的作用。药物洗脱支架、生物可吸收支架和先进成像技术等创新正在提高血管介入的有效性和安全性。这些尖端技术的引入预计将改善患者的治疗效果，并减少与传统设备相关的并发症。市场数据显示，药物洗脱设备的细分市场预计将见证显著增长，推动因素是其能够降低再狭窄率。随着制造商继续投资于研发，市场可能会出现一波新设备，以满足医疗专业人员和患者不断变化的需求。 ### 外周血管疾病发病率上升 外周血管疾病（PVD）的日益普遍是外周血管设备市场的主要驱动力。动脉粥样硬化和外周动脉疾病等病症在老年人群中变得越来越常见。根据最近的数据，PVD的发病率预计将显著上升，估计到2025年，近20%的65岁以上个体可能会受到影响。这一不断增长的患者群体需要开发和采用先进的外周血管设备，因为医疗服务提供者寻求有效的解决方案来管理这些病症。因此，对创新设备的需求，包括支架和球囊，可能会激增，从而推动市场增长。 ### 老龄化人口与生活方式变化 人口老龄化的趋势，加上生活方式的变化，是外周血管设备市场的重要驱动因素。随着人们年龄的增长，发展血管疾病的风险增加，从而导致对有效治疗方案的需求上升。此外，肥胖、久坐不动的生活方式和吸烟等生活方式因素也促使外周血管疾病的发生率上升。数据显示，到2050年，65岁及以上的人口预计将翻一番，进一步加大了对外周血管设备的需求。这一人口趋势为制造商提供了创新和扩展产品供应以满足这一日益增长的患者群体的重大机会。 ## Future Outlook 外周血管设备市场预计将在2024年至2035年间以4.52%的年均增长率增长，推动因素包括技术进步、血管疾病的日益普遍以及医疗支出的增加。 **New opportunities:** - 开发用于门诊手术的微创外科设备。 在新兴市场扩展，提供量身定制的产品。 整合基于人工智能的分析，以提供个性化的患者护理解决方案。 到2035年，市场预计将实现强劲增长，确立其在血管健康解决方案领域的领导地位。 ## Segment Insights ### 按设备类型：支架（最大）与导管（增长最快） 在外周血管设备市场中，支架占据了最大的市场份额，代表了总需求的一个重要部分。它们的受欢迎程度源于在治疗血管疾病中的广泛应用，使其成为血管介入的主流。然而，导管细分市场正在迅速获得关注，成为增长最快的类别。这是由于微创手术数量的增加和导管技术的进步，使得对外周血管疾病的治疗更加有效。 支架（主导）与导管（新兴） 支架被认为是外周血管设备市场的主导细分市场，主要用于有效治疗动脉阻塞。它们在临床实践中的既定角色使其成为医生的首选解决方案，导致其在各种应用中的广泛使用。相比之下，导管代表了一个新兴细分市场，其特点是创新和多功能性。随着材料和技术的进步，导管在诊断和治疗程序中的使用频率越来越高。它们的灵活性和易用性推动了其增长，为传统外科方法提供了可行的替代方案，并使其在医疗行业中更有可能被广泛采用。 ### 按应用：外周动脉疾病（最大）与静脉血栓栓塞（增长最快） 在外周血管设备市场中，外周动脉疾病（PAD）占据了最大的市场份额，反映出其显著的流行程度以及对有效治疗方案日益增长的需求。该细分市场受到生活方式相关疾病发病率上升和老龄化人口的推动，这直接导致了对血管干预的需求。相比之下，静脉血栓栓塞（VTE）在该细分市场中代表了增长最快的应用，受到对该病症认识提高和促进治疗与预防的导管设备进步的推动。 外周动脉疾病（显性）与静脉血栓栓塞（新兴） 外周动脉疾病（PAD）在外周血管设备市场中仍然占据主导地位，这主要归因于动脉粥样硬化的高发病率以及有效干预策略的重要性。需要进行血管成形术和支架植入的患者数量不断增加，进一步增强了PAD的市场实力。另一方面，静脉血栓栓塞（VTE）正在迅速崛起，得益于设备技术的创新以及向预防性医疗措施的转变。对VTE潜在并发症的日益认识正在推动对研发的投资，突显出向更高效和更少侵入性治疗选择的趋势。 ### 按材料：金属（最大）与可生物降解（增长最快） 外周血管设备市场在其材料细分中展示了多样的分布，其中金属材料占据了最大的份额。这种主导地位源于金属设备，特别是不锈钢和钴铬合金的可靠性和性能，这些材料因其耐用性和治疗效果而受到青睐。相比之下，生物可降解细分市场正在迅速获得关注，推动因素是对环保解决方案的需求增加以及设备移除后患者结果的改善。 金属（主导）与可生物降解（新兴） 外周血管器械市场中的金属材料，主要由不锈钢和钴合金组成，由于其经过验证的强度和与各种血管应用的兼容性，仍然占据主导地位。这些器械因其坚固的机械性能而受到青睐，适合用于永久植入物。另一方面，生物可降解材料呈现出一种新兴趋势，因其在完成使命后能够溶解，从而减少了额外手术的需求而受到关注。聚合物科学的进步使生物可降解器械的性能得到了提升，符合可持续医疗解决方案的趋势。 ### 按方式：微创（最大）与侵入性（增长最快） 外周血管设备市场展示了多种模式，包括侵入性、微创和非侵入性设备。在这些模式中，微创细分市场占据了最大的市场份额，因其减少恢复时间和降低并发症风险等优点而受到医疗服务提供者和患者的青睐。相比之下，侵入性细分市场由于技术进步和采用率增加而迅速获得关注，成为该领域增长最快的模式。随着医疗技术的发展，外周血管设备市场的增长趋势表明，手术方法的增强正在推动微创技术的普及。外周血管疾病的发病率上升、老龄化人口以及对治疗选择的认识提高等因素，均为该细分市场的强劲增长预测做出了贡献。因此，微创和侵入性模式都面临积极的发展，反映出一个动态的市场格局。 方式：微创（主导）与侵入性（新兴） 微创技术目前是外周血管设备市场的主导力量，其特点是涉及最小切口和缩短住院时间的一系列程序。这些技术因其在改善患者恢复体验的同时保持有效治疗结果的好处而受到青睐。该类别中的关键设备包括血管成形术导管和支架，由于其高效性和安全性，使用越来越广泛。尽管侵入性技术正在兴起，但也不容忽视，因为它涵盖了更传统的技术，在特定医疗场景中提供独特的优势。这些程序通常涉及对血管系统的直接访问，允许进行广泛的治疗选择。创新技术和方法的整合使得侵入性领域得以发展，成为医疗服务提供者和寻求强大治疗方式的患者的有吸引力的选择。 ## Regional Market Share Analysis ### 北美：创新的市场领导者 北美是外周血管设备最大的市场，占全球市场份额的约45%。该地区的增长受到老龄化人口、血管疾病患病率上升和医疗技术进步的推动。来自FDA等机构的监管支持也促进了创新和新设备的市场准入，提升了患者护理和治疗效果。美国是该市场的主要贡献者，主要参与者包括美敦力、波士顿科学和雅培实验室，主导着竞争格局。先进的医疗基础设施和对研发的重大投资进一步巩固了北美的地位。该市场的特点是快速的技术进步和对微创手术的关注，这在医疗服务提供者中越来越受到欢迎。 ### 欧洲：新兴的监管框架 欧洲是外周血管设备第二大市场，约占全球市场份额的30%。该地区的增长得益于对血管疾病的认识提高、老年人口增加以及支持性的监管框架。欧洲药品管理局（EMA）在简化创新设备的审批流程方面发挥了重要作用，促进了市场扩展的良好环境。该地区的主要国家包括德国、法国和英国，主要参与者如B. Braun Melsungen AG和飞利浦积极参与其中。竞争格局以合作和伙伴关系为特征，旨在增强产品供应。对以患者为中心的解决方案和技术进步的关注正在推动市场向前发展，使欧洲成为外周血管设备市场的关键参与者。 ### 亚太地区：快速增长潜力 亚太地区在外周血管设备市场上正经历快速增长，约占全球市场份额的20%。该地区的扩展受到医疗支出增加、对血管疾病认识提高和人口增长的推动。中国和印度等国在这一增长中处于领先地位，得益于政府旨在改善医疗基础设施和获取先进医疗技术的举措。中国是该地区最大的市场，地方制造商和国际参与者如Terumo Corporation和Cook Medical的贡献显著。竞争格局正在演变，重点关注设备的可负担性和可及性。随着这些国家的医疗系统不断发展，对创新和有效的外周血管解决方案的需求预计将上升，使亚太地区在未来几年成为一个关键市场。 ### 中东和非洲：未开发的市场机会 中东和非洲地区在外周血管设备市场上逐渐崭露头角，约占全球市场份额的5%。增长受到对医疗基础设施投资增加、慢性疾病患病率上升以及改善医疗服务可及性关注增加的推动。各国政府正在实施政策以增强医疗服务，这预计将推动该地区对先进医疗设备的需求。南非和阿联酋等国在市场中处于领先地位，国际参与者的存在日益增强。竞争格局以旨在增强产品可用性的合作和伙伴关系为特征。随着医疗系统的发展，对外周血管设备的需求预计将增长，为该地区的市场参与者提供显著机会。 ## Competitive Benchmarking 外周血管设备市场的特点是动态的竞争格局，受到技术进步、血管疾病的日益普遍以及日益增长的老龄化人口的推动。主要参与者如美敦力（美国）、波士顿科学（美国）和雅培实验室（美国）战略性地定位以利用创新并扩大其市场存在。美敦力（美国）专注于通过持续创新来增强其产品组合，而波士顿科学（美国）则强调战略合作伙伴关系以增强其研发能力。雅培实验室（美国）积极追求区域扩张，特别是在新兴市场，这共同塑造了一个越来越依赖技术差异化和战略合作的竞争环境。 外周血管设备市场的关键商业策略包括本地化制造和优化供应链以提高运营效率。市场结构似乎适度分散，几家主要参与者施加着显著影响。这种分散性允许多样化的产品和创新，但美敦力（美国）和波士顿科学（美国）等主要公司的集体实力表明，竞争动态既是合作的也是竞争的，因为这些公司寻求通过创新和市场渗透建立领导地位。 在2025年8月，美敦力（美国）宣布推出其下一代药物涂层气球技术，旨在改善外周动脉疾病患者的治疗效果。这一战略举措不仅强化了美敦力对创新的承诺，还使公司能够在日益增长的微创血管干预市场中占据更大份额。这项技术的引入可能会通过满足未满足的临床需求和提高程序效率来增强美敦力的竞争优势。 在2025年9月，波士顿科学（美国）与一家领先的数字健康公司达成合作，以将人工智能整合到其血管设备产品中。此次合作旨在通过数据驱动的洞察来增强患者监测和治疗效果。通过拥抱人工智能，波士顿科学（美国）不仅增强了其产品能力，还使其与医疗保健数字化转型的更广泛趋势保持一致，这可能显著改善其市场定位。 在2025年7月，雅培实验室（美国）在亚洲扩大了其制造能力，以满足该地区对外周血管设备日益增长的需求。这一战略扩张表明雅培对区域增长的关注及其确保供应链可靠性的承诺。通过本地化生产，雅培可能会减少交货时间和成本，从而在快速发展的市场中增强其竞争地位。 截至2025年10月，外周血管设备市场正在见证数字化、可持续性和人工智能整合等趋势，这些趋势正在重新定义竞争动态。战略联盟越来越多地塑造市场格局，因为公司认识到合作在推动创新中的价值。展望未来，竞争差异化预计将从传统的基于价格的竞争演变为关注技术进步、创新解决方案和强大的供应链管理，强调在快速变化的市场中适应能力的重要性。 ## Recent News & Developments - **2024年第二季度：MicroVention在美国推出LVIS EVO腔内支撑装置** MicroVention，Terumo的一个部门，于2024年6月在美国正式推出其LVIS EVO腔内支撑装置。该新支架旨在为复杂血管疾病提供先进的腔内支撑。 ## Report Scope | 2024年市场规模 | 239.9（十亿美元） | | --- | --- | | 2025年市场规模 | 250.8（十亿美元） | | 2035年市场规模 | 390.2（十亿美元） | | 复合年增长率（CAGR） | 4.52%（2024 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 十亿美元 | | 主要公司简介 | 市场分析进行中 | | 覆盖的细分市场 | 市场细分分析进行中 | | 主要市场机会 | 先进成像技术的整合提高了外周血管设备市场的程序准确性。 | | 主要市场动态 | 技术进步和监管变化推动外周血管设备市场的创新和竞争。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: 2035年外周血管设备市场的预计市场估值是多少？** A: 预计到2035年，外周血管设备市场的市场估值为390.2亿美元。 **Q: 2024年外周血管设备市场的整体市场估值是多少？** A: 2024年外周血管设备市场的整体市场估值为239.9亿美元。 **Q: 在2025年至2035年的预测期内，外周血管设备市场的预期CAGR是多少？** A: 在2025年至2035年的预测期内，外周血管设备市场的预期CAGR为4.52%。 **Q: 在外周血管设备市场中，哪些公司被视为关键参与者？** A: 外周血管设备市场的主要参与者包括美敦力、波士顿科学、雅培实验室等。 **Q: 到2035年，外周血管设备市场中支架的预计估值是多少？** A: 到2035年，外周血管设备市场中支架的预计估值预计将达到80亿至110亿美元。 **Q: 到2035年，导管市场与内支架市场相比如何？** A: 到2035年，导管市场预计将达到90亿至120亿美元，而内支架市场可能达到60亿至80亿美元。 **Q: 到2035年，外周动脉疾病应用的预期市场规模是多少？** A: 预计到2035年，外周动脉疾病应用的市场规模将介于95亿至120亿美元之间。 **Q: 到2035年，预计哪些材料将在外周血管设备市场中占主导地位？** A: 到2035年，金属和镍钛合金材料预计将在外周血管设备市场中占主导地位，估值分别为120亿美元和80亿美元。 **Q: 2035年微创治疗方式的预计市场规模是多少？** A: 预计到2035年，微创治疗方式的市场规模将介于160亿至200亿美元之间。 **Q: 到2035年，静脉血栓栓塞应用市场与颈动脉疾病市场相比如何？** A: 到2035年，静脉血栓栓塞应用市场预计将达到60亿至80亿美元，而颈动脉疾病的市场可能达到100亿至120亿美元。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/peripheral-vascular-device-market-30187*